- Home
- KPRX vs QH Comparison
KPRX vs QH Comparison
Compare KPRX & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | QH |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 9.8M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KPRX | QH |
|---|---|---|
| Price | $2.29 | $2.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.4K | 10.1K |
| Earning Date | 11-06-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.76 | $0.07 |
| 52 Week High | $2.91 | $12.81 |
Technical Indicators
Market Signals| Indicator | KPRX | QH |
|---|---|---|
| Relative Strength Index (RSI) | 26.13 | 27.52 |
| Support Level | $1.94 | $0.90 |
| Resistance Level | $2.72 | $4.07 |
| Average True Range (ATR) | 0.07 | 0.27 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.45 | 0.00 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.